G protein-coupled receptor
δ-opioid receptor
Delta opioid receptor
- GeneOPRD1
- FamilyOpioid receptors
- GroupOpioid receptors
The δ-opioid receptor was cloned by expression from the NG108-15 cell line. It has the structure of a G protein-coupled receptor, and in cells it showed the binding profile of the native δ receptor.1
Autoradiography in the rat showed that delta binding is restricted to a few areas, among them the anterior cingulate cortex, the neocortex, the amygdala, the olfactory tubercle, the nucleus accumbens and the caudate putamen. The mRNA of the receptor differs from those of the mu and kappa receptors and is found in the olfactory bulb, the allo- and neocortex, the caudate-putamen, the nucleus accumbens, the olfactory tubercle, the ventromedial hypothalamus, the hippocampus, the amygdala, the red nucleus, the pontine nuclei, the spinal cord and the dorsal root ganglia.2,3
The receptor is broadly expressed in the brain, binds endogenous opioid peptides and has a functional profile that is highly distinct from those of the mu and kappa receptors. Beneficial effects of DOR agonists are well established for emotional responses and mood disorders, and blocking the receptor increased anxiety-related behaviour in mice and rats. Activation of the receptor also regulates drug reward, inhibitory controls and learning, but whether delta compounds could treat drug abuse remains open.4
Mice without it show more anxiety-like and depression-like behaviour, the opposite of mice without the μ receptor.5
Delta receptors are a promising target for new analgesics. Novel delta agonists with potent analgesic properties and mouse models with mutations in the delta receptor gene have improved the knowledge of the role of the receptor in pain control. The regulation of the receptor at the cellular level affects its pain-reducing activity.6 Delta agonists can also cause convulsions. The agonists BW373U86 and SNC80 failed to produce convulsive behaviour in mice lacking the receptor, which shows that the receptor is absolutely involved. In normal mice BW373U86 produced both antinociception and convulsive activity through the same type of receptor, but the receptor reserve for the convulsions is greater than for the antinociception. A review adds that the epileptogenic effects of delta agonists appear to depend on the drug.7,4
Sources (7)
- Kieffer et al. 1992Kieffer BL, Befort K, Gaveriaux-Ruff C, et al. (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization Proc Natl Acad Sci U S A
- Mansour et al. 1987Mansour A, Khachaturian H, Lewis ME, et al. (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain J Neurosci
- Mansour et al. 1994Mansour A, Fox CA, Burke S, et al. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study J Comp Neurol
- Chu Sin Chung et al. 2013Chu Sin Chung P, Kieffer BL (2013) Delta opioid receptors in brain function and diseases Pharmacol Ther
- Filliol et al. 2000Filliol D, Ghozland S, Chluba J, et al. (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses Nat Genet
- Gavériaux-Ruff et al. 2011Gavériaux-Ruff C, Kieffer BL (2011) Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches Behav Pharmacol
- Broom et al. 2002Broom DC, Nitsche JF, Pintar JE, et al. (2002) Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice J Pharmacol Exp Ther
Binding affinity (Kᵢ)
12 substances, 19 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
7 measurements
Buprenorphine4.5 nMToll et al. 1998 · 2 reports
- Assay
- human DOR in CHO cells, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Range
- 1.5–4.5 nM in 2 reports
- Error
- ± 0.40 SD
Sources and values behind the range, same assay family Report Value Where Toll et al. 1998 4.5 nM Table 5 Obeng et al. 2021 1.5 nM Table 2 Hydromorphone38 nMWentland et al. 2009
- Assay
- CHO cell membranes expressing the human DOR, [3H]naltrindole displacement
- Shown value from
- Wentland et al. 2009, Table 1
Methadone132 nMToll et al. 1998
- Assay
- human DOR in CHO cells, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 11 SD
Morphine140 nMNeumeyer et al. 2012 · 3 reports
- Assay
- CHO cells expressing human DOR, [3H]naltrindole competition
- Shown value from
- Neumeyer et al. 2012, Table 2
- Range
- 140–250 nM in 3 reports
- Error
- ± 18 SEM
Sources and values behind the range, same assay family Report Value Where Neumeyer et al. 2012 140 nM Table 2 Toll et al. 1998 140 nM Table 5 Obeng et al. 2021 250 nM Table 2 Fentanyl153 nMToll et al. 1998 · 2 reports
- Assay
- human DOR in CHO cells, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Range
- 153–539 nM in 2 reports
- Error
- ± 38 SD
Reported values disagree and no value is established. 2 reports in all, 153–539 nM.
Sources and values behind the range, same assay family Report Value Where Toll et al. 1998 153 nM Table 5 Obeng et al. 2021 539 nM Table 2 7-Hydroxymitragynine219 nMKruegel et al. 2016 · 2 reports
- Assay
- cells expressing human DOR, opioid receptor binding
- Shown value from
- Kruegel et al. 2016, Table 2
- Range
- 219–243 nM in 2 reports
- Error
- ± 41 SEM
Sources and values behind the range, same assay family Report Value Where Obeng et al. 2021 243 nM Table 2 Kruegel et al. 2016 219 nM Table 2 Mitragynine6800 nMObeng et al. 2021
- Assay
- CHO cells expressing hDOR, [3H]DADLE competition
- Shown value from
- Obeng et al. 2021, Table 2
Guinea pig
4 measurements
Buprenorphine1.6 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 0.07 SD
Methadone37 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 2.3 SD
Morphine50 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 0.60 SD
Fentanyl74 nMToll et al. 1998
- Assay
- guinea-pig brain membranes, [3H]Cl-DPDPE competition
- Shown value from
- Toll et al. 1998, Table 5
- Error
- ± 3.5 SD
Mouse
1 measurement
Buprenorphine0.42 nMHuang et al. 2001
- Assay
- recombinant mouse DOR in CHO membranes, [3H]diprenorphine competition
- Shown value from
- Huang et al. 2001, Table 1
- Error
- ± 0.04 SEM, n = 4
Rat
6 measurements
Oxymorphone81 nMBen Haddou et al. 2014
- Assay
- native rat brain membranes, [3H][Ile5,6]deltorphin II competition
- Shown value from
- Ben Haddou et al. 2014, Table 1
- Error
- ± 5.5 SEM
Morphine217 nMBen Haddou et al. 2014 · 2 reports
- Assay
- native rat brain membranes, [3H][Ile5,6]deltorphin II competition
- Shown value from
- Ben Haddou et al. 2014, Table 1
- Range
- 80–217 nM in 2 reports
- Error
- ± 19 SEM
Sources and values behind the range, same assay family Report Value Where Ben Haddou et al. 2014 217 nM Table 1 Tzschentke et al. 2007 80 nM Table 1 Oxycodone958 nMMonory et al. 1999
- Assay
- rat brain membranes, displacement of [3H]naltrindole
- Shown value from
- Monory et al. 1999, Table II
Tapentadol970 nMTzschentke et al. 2007
- Assay
- rat opioid receptor binding assay
- Shown value from
- Tzschentke et al. 2007, Table 1
- Error
- ± 10 SEM
3-HO-PCP2300 nMItzhak et al. 1981
- Assay
- rat brain homogenate (minus cerebellum), [3H]leucine-enkephalin 1.0 nM, delta site
- Shown value from
- Itzhak et al. 1981, Table 1B
Codeine5500 nMTzschentke et al. 2007
- Assay
- rat opioid receptor binding assay
- Shown value from
- Tzschentke et al. 2007, Table 1
- Error
- ± 600 SEM
Unspecified
1 measurement
Mitragynine2250 nMLydecker et al. 2016
- Assay
- DOR opioid receptor binding, quoted in a review table (original assay not restated)
- Shown value from
- Lydecker et al. 2016, Table 1
Functional potency (EC₅₀)
5 substances, 5 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
4 measurements
Oxymorphone259 nMBen Haddou et al. 2014
- Assay
- CHO cells expressing human opioid receptor, [35S]GTPγS functional assay
- Shown value from
- Ben Haddou et al. 2014, Table 2
- Error
- ± 33 SEM
- Emax
- 87.0 ± 40.0%
Fentanyl515 nMToll et al. 1998
- Assay
- human DOR-CHO cell membranes, [35S]GTPgammaS binding
- Shown value from
- Toll et al. 1998, Table 7
- Error
- ± 102 SD
- Emax
- 86.0 ± 19.0%
Morphine668 nMBen Haddou et al. 2014 · 2 reports
- Assay
- CHO cells expressing human opioid receptor, [35S]GTPγS functional assay
- Shown value from
- Ben Haddou et al. 2014, Table 2
- Range
- 317–668 nM in 2 reports
- Error
- ± 65 SEM
- Emax
- 109.0 ± 14.0%
Sources and values behind the range, same assay family Report Value Where Ben Haddou et al. 2014 668 nM Table 2 Toll et al. 1998 317 nM Table 7 Methadone980 nMToll et al. 1998
- Assay
- human DOR-CHO cell membranes, [35S]GTPgammaS binding
- Shown value from
- Toll et al. 1998, Table 7
- Error
- ± 99 SD
- Emax
- 106.0 ± 21.0%
Mouse
1 measurement
7-Hydroxymitragynine664 nMKruegel et al. 2016
- Assay
- mouse DOR, G protein BRET assay, agonist mode (relative to DPDPE)
- Shown value from
- Kruegel et al. 2016, Supplement Table S1
- Emax
- 16.0%
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.